FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Swidler Pamela		 2. Date of Event Requiring Statement (MM/DD/YYYY)
2/21/2023 

 3. Issuer Name and Ticker or Trading Symbol

WeWork Inc. [WE]
(Last)        (First)        (Middle)

75 ROCKEFELLER PLAZA, 10TH FL		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
See Remarks /
(Street)

NEW YORK, NY 10019      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 21067 D  
Common Stock 6196 (1)D  
Common Stock 13769 (2)D  
Common Stock 33333 (3)D  
Common Stock 7184 (4)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)  (5)8/4/2026 Common Stock 3098 $4.99 D  
Stock Option (right to buy)  (6)1/18/2027 Common Stock 3178 $4.99 D  
Stock Option (right to buy)  (7)6/12/2028 Common Stock 547 $4.99 D  
Stock Option (right to buy)  (8)3/29/2029 Common Stock 8762 $4.99 D  
Stock Option (right to buy)  (9)2/10/2030 Common Stock 19828 $2.55 D  
Explanation of Responses:
(1) Represents unvested restricted stock units ("RSUs") granted on January 26, 2021 that convert into common stock on a one-for-one basis. The RSUs will vest on January 26, 2024.
(2) Represents unvested RSUs granted on August 10, 2021 that convert into common stock on a one-for-one basis. The RSUs will vest in equal installments on July 15, 2023 and July 15, 2024.
(3) Represents unvested RSUs granted on March 22, 2022 that convert into common stock on a one-for-one basis. The RSUs will vest in equal installments on January 10, 2024 and January 10, 2025.
(4) Represents unvested RSUs granted on March 22, 2022 that convert into common stock on a one-for-one basis. The RSUs will vest in equal installments on January 10, 2024 and January 10, 2025; provided however, that if the Issuer achieves a certain earnings before interest, taxes, depreciation, and amortization ("EBITDA") milestone no later than December 31, 2023, all of the RSUs will vest on January 10, 2024.
(5) Represents outstanding, unexercised stock options to purchase common stock granted on August 4, 2016. The options are fully vested and exercisable.
(6) Represents outstanding, unexercised stock options to purchase common stock granted on January 18, 2017. The options are fully vested and exercisable.
(7) Represents outstanding, unexercised stock options to purchase common stock granted on June 12, 2018. The options are fully vested and exercisable.
(8) Represents outstanding, unexercised stock options to purchase common stock granted on March 29, 2019. 25% of the options are vested and exercisable, 15% of the remaining options vest on each of March 16, 2023, March 16, 2024 and March 16, 2025, and the remaining 30% of the options vest on March 16, 2026.
(9) Represents outstanding, unexercised portion of stock options to purchase common stock granted on June 18, 2020. The options are fully vested and exercisable.

Remarks:
Exhibit 24 - Power of Attorney

Chief Legal Officer, Chief Compliance Officer and Secretary

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Swidler Pamela
75 ROCKEFELLER PLAZA, 10TH FL
NEW YORK, NY 10019

See Remarks
Signatures
/s/ Pamela Swidler2/28/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
BowX Acquisition (NASDAQ:BOWX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos BowX Acquisition.
BowX Acquisition (NASDAQ:BOWX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos BowX Acquisition.